Detalhe da pesquisa
1.
Oncological treatment administration at end of life: a retrospective study.
Future Oncol
; 20(6): 329-334, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38420932
2.
Comparison of different treatments for HPV+ oropharyngeal carcinoma: a network meta-analysis.
Eur Arch Otorhinolaryngol
; 280(3): 963-971, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36261656
3.
A European survey on the practice of nutritional interventions in head-neck cancer patients undergoing curative treatment with radio(chemo)therapy.
Eur Arch Otorhinolaryngol
; 279(3): 1499-1508, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34146151
4.
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial.
BMC Cancer
; 21(1): 561, 2021 May 17.
Artigo
Inglês
| MEDLINE | ID: mdl-34001010
5.
Immunotherapy for Nasopharyngeal Carcinoma: The Earlier the Better.
JAMA
; 330(20): 1954-1955, 2023 11 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38015229
6.
Where do we stand with immunotherapy for nonmelanoma skin cancers in the curative setting?
Curr Opin Otolaryngol Head Neck Surg
; 32(2): 89-95, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37997885
7.
The predictive role of PD-L1 in head and neck cancer: A systematic review and meta-analysis.
Oral Oncol
; 153: 106799, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38729036
8.
Evaluation of DNA methylation levels of SEPT9 and SHOX2 in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR.
Oncol Rep
; 51(3)2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38299234
9.
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab.
J Immunother Cancer
; 12(1)2024 01 30.
Artigo
Inglês
| MEDLINE | ID: mdl-38290766
10.
The present and the future of benzydamine: expert opinion paper.
Front Oral Health
; 4: 1191319, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37405329
11.
Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy.
Cancer Treat Rev
; 121: 102644, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37862833
12.
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports.
Front Oncol
; 13: 1111146, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36925925
13.
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways.
Sci Rep
; 13(1): 1809, 2023 01 31.
Artigo
Inglês
| MEDLINE | ID: mdl-36720951
14.
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma.
Oral Oncol
; 145: 106540, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37567147
15.
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study.
Sci Rep
; 12(1): 9951, 2022 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35705678
16.
Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal Cancers.
J Clin Med
; 11(22)2022 Nov 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36431263
17.
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders.
Front Oncol
; 12: 886404, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35530364
18.
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma.
Oral Oncol
; 126: 105764, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35158286
19.
Not all hematopoietic growth factors are created equal: should we gain information for their use with immunotherapy?
J Immunother Cancer
; 9(8)2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34429333
20.
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis.
Endocr Relat Cancer
; 28(8): 593-604, 2021 07 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34105516